The "KEY OF HOPE" program is aimed at increasing the awareness of patients about the disease and reducing the cost of therapy for the patient with drugs included in the Program, intended for the treatment of certain types of oncological diseases by influencing the immune system;
Preparation of the project:
KITRUDA® (pembrolizumab)
Keytruda conc. d/r-nu d/inf. 25 mg/ml fl. 4 ml No. 1
The promotion is held until: 31.12.2025
You can learn more about the terms of participation in the project on the website: https://medicard.com.ua/medicard/page/key_hope_ruless/

The "Asakard" program was developed by the Biocodex company in order to ease your burden during the long-term treatment of intestinal diseases.
Drugs:
ASAKOL® coated tablets, enteric-soluble 800 mg No. 60;
ASAKOL® coated tablets, enteric-soluble 400 mg No. 100;
ASAKOL® rectal suppositories of 500 mg No. 20.

You can learn more about the terms of participation in the project on the website:https://privit.com.ua/asacard/

"CHERVONA KALINA"

The goal of the Program is to improve access of Ukrainian patients to effective innovative treatment with medicines included in the Program.

The program is valid from October 1, 2023 to March 31, 2028 inclusive.

The patient support program "CHERVONA KALYNA" is implemented by Astellas Pharma LLC with information and technical support from Medicard LLC

More information about the conditions for participation in the project can be found on the project website.

AFFORDABLE PROTECTION OF THE LIVER AND GALLBLADDER
The hepatobiliary system includes the liver, gallbladder, intrahepatic and extrahepatic bile ducts. Functional disorders of the hepatobiliary system occupy a significant place among diseases of the gastrointestinal tract. Pathologies associated with the formation and secretion of bile are especially common.

High-quality treatment of disorders of the hepatobiliary system increases the chances of a full recovery and prevents the appearance of complications.

If your doctor has prescribed you a medicine that is part of the "AFFORDABLE PROTECTION OF THE LIVER AND GALLBLADDER" program, you can become its participant and receive medicines included in the Program at a discount at partner pharmacies.

The patient support program aims to make treatment of patients with heart failure with reduced ejection fraction more accessible

The program "PATH TO A HEALTHY HEART" is implemented on the initiative of PJSC "PHARMACEUTICAL COMPANY "DARNYTSYA" with the technical support of LLC "MEDYCARD PLUS"

More details about the terms of participation in the project can be found on the project website

Patient Support Program "Free Movement Without Pain"

The social patient support program aims to increase awareness and accessibility of therapies for the treatment of patients with joint pain.

Information can be found on the website https://medicard.com.ua/medicard/page/movement_wo_pain/

Take control of your blood pressure

The social patient support program aims to make quality antihypertensive therapy more accessible.

Information can be found on the website https://medicard.com.ua/medicard/page/control_your_pressure/

Migraine is not a sentence

The social patient support program aims to increase awareness and accessibility of therapy for the treatment of patients with migraine.

Information can be found on the website https://medicard.com.ua/medicard/page/migraine_not_doom/

the company is focused on the key needs in healthcare, the development of new medicines, technologies and treatments. This is an international diversified company operating in the health sector. Time-tested products are highly appreciated by experts worldwide for its efficiency, reliability and safety. Program Time (ABBOTT CARDS ) provides the opportunity to purchase efficient medications at a more affordable price.

Drugs project:

Heptral since.lyophil.d/R-RA d/INF.500mg FL., No. The 5+solution.amp.5ml No. 5
Heptral tab.enteric solution.500 mg No. 20

More details about conditions of participation in the project can be found on the project website Abbott cards

“PLUS Therapy” – the program aims to support patients with chronic diseases in areas such as cardiology, endocrinology, pneumology, psychiatry and Oncology. For each Drug, which participates in the Program, define an appropriate charging scheme discounts. The discount is given to cardholders ‘Terapias”, which are issued to patients who had been prescribed the drug involved in the Program “Terapias”, by a doctor of the healthcare institution.

Drugs project:

Ось переклад англійською мовою:

• Brilinta film-coated tablets 90 mg No. 56

• Brilinta film-coated tablets 60 mg No. 56

• Kombiglyze XR film-coated tablets 5 mg / 1000 mg No. 28

• Crestor film-coated tablets 10 mg No. 28

• Crestor film-coated tablets 20 mg No. 28

• Crestor film-coated tablets 40 mg No. 28

• Crestor film-coated tablets 5 mg No. 28

• Onglyza film-coated tablets 5 mg No. 30

• Xigduo XR prolonged-release film-coated tablets 10 mg / 1000 mg No. 28

• Xigduo XR prolonged-release film-coated tablets 5 mg / 1000 mg No. 28

• Trixeo Aerosphere pressurized inhalation suspension 5 / 7.2 / 160 mcg, 120-dose canister No. 1

More details about conditions of participation in the project can be found on the project website Therapy PLUS

“the MAP of hope” – program to SUPPORT patients  in areas such as  Oncology.

Drugs project:

Ось переклад англійською мовою:

• Tagrisso film-coated tablets 80 mg No. 30 (10×3)

• Lynparza film-coated tablets 100 mg No. 56

• Lynparza film-coated tablets 150 mg No. 56

• Calquence hard capsules 100 mg No. 60

• Calquence film-coated tablets 100 mg No. 60

More details about conditions of participation in the project can be found on https://kartanadii.com.ua/az_onko/

the aim of the Programme – ensuring patient access to quality medicines, by reducing the cost of drugs.

Drugs project:

Asteron R-R d/in.2.25 mg/ml amp.1 ml №25

the Program "Smart start" is created to facilitate patients ' access to
the drugs used in diabetes.

Drugs project:
Tresiba Flekstach, № 5, 3 ml
Rayzodeg Flekstach, № 5, 3 ml
Ksaltofy, № 5, 3ml 

More details about conditions of participation in the project can be found at: https://medicard.com.ua/medicard/page/programms/